These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


413 related items for PubMed ID: 6522309

  • 1. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA, Resnick RB, Resnick E.
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [Abstract] [Full Text] [Related]

  • 2. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS, Rawson RA, Cohen AJ, Mann A.
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [Abstract] [Full Text] [Related]

  • 6. Treatment of heroin addicts using buprenorphine.
    Kosten TR, Morgan C, Kleber HD.
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [Abstract] [Full Text] [Related]

  • 7. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X, Khazaal Y, Besson J, Zullino DF.
    Eur Addict Res; 2007 Jun; 13(1):20-4. PubMed ID: 17172775
    [Abstract] [Full Text] [Related]

  • 8. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
    Tait RJ, Ngo HT, Hulse GK.
    J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
    [Abstract] [Full Text] [Related]

  • 9. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H, Stancliff S, Langrod J.
    Mt Sinai J Med; 2000 Sep; 67(5-6):347-64. PubMed ID: 11064485
    [Abstract] [Full Text] [Related]

  • 10. Operant analysis of human heroin self-administration and the effects of naltrexone.
    Mello NK, Mendelson JH, Kuehnle JC, Sellers MS.
    J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M, McIntosh J, McKeganey N, Robertson M.
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers.
    Shi J, Zhao LY, Epstein DH, Zhang XL, Lu L.
    Pharmacol Biochem Behav; 2007 May; 87(1):141-5. PubMed ID: 17532034
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [Abstract] [Full Text] [Related]

  • 16. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Preliminary evaluation of methadone program in Kraków].
    Kamenczak A, Chrostek Maj J, Kroch S, Groszek B.
    Przegl Lek; 2000 May; 57(10):525-30. PubMed ID: 11199879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
    Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, Davoli M, Amato L, Perucci CA, Faggiano F, VEdeTTE Study Group.
    Subst Use Misuse; 2010 Oct; 45(12):2076-92. PubMed ID: 20438317
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.